Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553564 · ClinicalTrials.gov registry record · NA
30 Day Rehospitalization Risk in Hemodialysis Patients
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02553564 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 3 participants.
The verdict
NCT02553564, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
After a hospitalization, dialysis patients have a high risk of being admitted to the hospital again within 30 days. The purpose of this research study is to test a new way of reducing the chance of patients being hospitalized again. In this study investigator will evaluate a checklist driven evaluation upon return to the dialysis facility as a method to reduce the rate of rehospitalizations in hemodialysis patients.
Interventions
- OTHER Checklist driven clinical encounter after hospital discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-11-22 |
| Est. Completion | 2018-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02553564
The ClinicalTrials.gov registry entry for NCT02553564 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Checklist driven clinical encounter after hospital discharge is the first listed.
NCT02553564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02553564 about?
NCT02553564 is a clinical study titled "30 Day Rehospitalization Risk in Hemodialysis Patients". After a hospitalization, dialysis patients have a high risk of being admitted to the hospital again within 30 days. The purpose of this research study is to test a new way of reducing the chance of patients being hospitalized again. In this study investigator will evaluate a checklist driven evaluat...
What is the current status of trial NCT02553564?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-11-22. Estimated completion is 2018-03-15.
What interventions are being tested in trial NCT02553564?
The interventions under investigation include: Checklist driven clinical encounter after hospital discharge (OTHER).
Who is sponsoring clinical trial NCT02553564?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.